Navigation Links
Inclement East Coast Weather Delays ProUroScan(TM) FDA Review
Date:2/26/2010

MINNEAPOLIS, Feb. 26 /PRNewswire-FirstCall/ -- ProUroCare Medical, Inc. (OCT Bulletin Board: PUMD, PUMDU, PUMDW), a provider of proprietary medical imaging products, indicates that the Food and Drug Administration has informed the industry that the processing of 510(k) applications, which includes the ProUroScan™ prostate imaging system, has been delayed because of the inclement weather in February that impacted the Washington, D.C. area.  It is anticipated that the delay will not be significant.

About ProUroCare Medical, Inc.

ProUroCare Medical, Inc. is a publicly traded company engaged in the business of creating innovative medical imaging products. The company's current focus is the ProUroScan prostate imaging system, which is now in clinical trials for the mapping of prostate abnormalities detected by DRE. Based in Minneapolis, Minn., ProUroCare is traded on the OTCBB market.

Safe Harbor Statement

This news release contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are typically preceded by words such as "believes," "expects," "anticipates," "intends," "will," "may," "should," or similar expressions. These forward-looking statements are not guarantees of ProUroCare's future performance and involve a number of risks and uncertainties that may cause actual results to differ materially from the results discussed in these statements. Factors that might cause ProUroCare's results to differ materially from those expressed or implied by such forward-looking statements are detailed from time to time in ProUroCare's filings with the Securities and Exchange Commission including its most recently filed Form 10-K and Form 10-Q.

SOURCE ProUroCare Medical, Inc.

Back to top
'/>"/>
SOURCE ProUroCare Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
2. Congressional Sting Operation Uncovered By Coast IRB
3. Pharmatek Laboratories Announces Acquisition of the First Xcelodose(R) 600S System on the West Coast
4. Eli Lilly and Company Opens Eco-Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation
5. First Coast Oncology Deploying Both Naviscan(TM) PEM and AccuBoost(TM) Assisted Therapy to Optimize Breast Cancer Treatment
6. CVS/pharmacy and MinuteClinic to Provide H1N1 Vaccinations Coast to Coast
7. Exenatide Once Weekly New Drug Application Review Extended By FDA Due to Weather-Related Closure
8. Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer
9. Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
10. Is Poor Medical Equipment Planning Costing your Healthcare Project Wasted Dollars and Delays? ECRI Institute outlines best practices to ensure better outcomes
11. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... TOKYO , April 28, 2016 /PRNewswire/ ... Ahuja , George Phillips und ... wachsenden Unternehmens    ArisGlobal®, ein ... Life Sciences, gab heute bekannt, dass neue ... wachsenden Unternehmens gestoßen sind, die vielfältige Erfahrungen ...
(Date:4/28/2016)... JERUSALEM , April 28, 2016 ... ), a clinical-stage pharmaceutical company focused on the development of ... participate in the upcoming PIONEERS 2016 conference, presented by ... 5, 2016 in New York . ... overview at the conference. Presentation Details:   ...
(Date:4/27/2016)... April 27, 2016  Hologic, Inc. (Nasdaq: ... results for the fiscal second quarter ended March ... of $0.24 increased 41.2%, and non-GAAP diluted EPS ... increased 5.8% on a reported basis, and 6.3% ... "We posted another good quarter, highlighted by 14.6% ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... May 02, 2016 , ... Over $60 Billion is spent annually on products ... toys, leading product review site for Toys, Tots, Pets & More (TTPM) announced the ... Spring Showcase at the Metropolitan Pavilion in New York City. , Chosen from a ...
(Date:5/2/2016)... NY (PRWEB) , ... May 02, 2016 , ... This ... reopened for its 2016 guest season which runs through October. Omega is offering a ... . , “There has never been such widespread interest in or need ...
(Date:5/2/2016)... County, CA (PRWEB) , ... May 02, 2016 , ... ... now linking dental health and cognitive decline. According to the research, which was published ... have some degree of cognitive decline, and about 5.4 million Americans have Alzheimer’s disease. ...
(Date:5/2/2016)... (PRWEB) , ... May 02, ... ... researchers report that many commonly used prescription medications, including anxiolytics, painkillers, antidepressants ... mitigate these risks, Novus Medical Detox Center —a leading Florida-based drug ...
(Date:5/2/2016)... Brentwood, TN (PRWEB) , ... May 02, 2016 ... ... American Addiction Centers (AAC) event, will be held at the Bellagio Hotel in ... National Association of Social Work (NASW) will be co-hosting the event. , This ...
Breaking Medicine News(10 mins):